Floatz logo

11 assets in Exocrine Pancreatic Insufficiency

Therapeutic assets addressing Exocrine Pancreatic Insufficiency, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pancrelipase
Exocrine Pancreatic Insufficiency
Anagram Therapeutics, Inc.P4A (80)
Adrulipase Alfa
Exocrine Pancreatic Insufficiency
Entero TherapeuticsP2BB (67)
ang003
Exocrine Pancreatic Insufficiency
Anagram Therapeutics, Inc.P2B (60)
Dulaglutide
Exocrine Pancreatic Insufficiency
University of PennsylvaniaP2CCC (53)
nhs7108
Exocrine Pancreatic Insufficiency
Aimmune Nestlé Health Science US R&D, LLCP2CCC (53)
Dorzagliatin
Exocrine Pancreatic Insufficiency
University of PennsylvaniaP1CC (43)
Aspergillus Oryzae Proteinase
Exocrine Pancreatic Insufficiency
Changhai HospitalN/AD (30)
Gip
Exocrine Pancreatic Insufficiency
University of PennsylvaniaN/AD (30)
Glimepiride
Exocrine Pancreatic Insufficiency
Changhai HospitalN/AD (30)
Glucagon-Like Peptide 1, Human
Exocrine Pancreatic Insufficiency
University of PennsylvaniaN/AD (30)
Glucophage
Exocrine Pancreatic Insufficiency
Changhai HospitalN/AD (30)